Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people: prevalence and comparative meta-analysis including 4 717 839 people

Gespeichert in:
Bibliographische Detailangaben
Titel: Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people: prevalence and comparative meta-analysis including 4 717 839 people
Autoren: Alessandro Miola, Paolo Fusar-Poli, Brendon Stubbs, Marco Solmi, Ai Koyanagi, Michele Fornaro, Christoph U. Correll, Elisabetta Frison, Steve Kisely, Elena Dragioti, Jae Il Shin, Joseph Firth, André F. Carvalho
Weitere Verfasser: Solmi, M., Firth, J., Miola, A., Fornaro, M., Frison, E., Fusar-Poli, P., Dragioti, E., Shin, J. I., Carvalho, A. F., Stubbs, B., Koyanagi, A., Kisely, S., Correll, C. U., Marco Solmi, Joseph Firth, Alessandro Miola, Michele Fornaro, Elisabetta Frison, Paolo Fusar-Poli, Elena Dragioti, Jae Il Shin, Andrè F Carvalho, Brendon Stubbs, Ai Koyanagi, Steve Kisely, Christoph U Correll, Shin, Jae Il
Quelle: The lancet. Psychiatry
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Solmi, M, Firth, J, Miola, A, Fornaro, M, Frison, E, Fusar-Poli, P, Dragioti, E, Shin, J I, Carvalho, A F, Stubbs, B, Koyanagi, A, Kisely, S & Correll, C U 2020, ' Disparities in cancer screening in people with mental illness across the world versus the general population : prevalence and comparative meta-analysis including 4 717 839 people ', The Lancet Psychiatry, vol. 7, no. 1, pp. 52-63 . https://doi.org/10.1016/S2215-0366(19)30414-6
Solmi, M, Firth, J, Miola, A, Fornaro, M, Frison, E, Fusar-Poli, P, Dragioti, E, Shin, J I, Carvalho, A F, Stubbs, B, Koyanagi, A, Kisely, S & Correll, C U 2020, 'Disparities in cancer screening in people with mental illness across the world versus the general population : prevalence and comparative meta-analysis including 4 717 839 people', The Lancet Psychiatry, vol. 7, no. 1, pp. 52-63. https://doi.org/10.1016/S2215-0366(19)30414-6
Verlagsinformationen: Elsevier BV, 2020.
Publikationsjahr: 2020
Schlagwörter: Bipolar Disorder, Major Depressive Disorder, Uterine Cervical Neoplasms, Clinical sciences, Breast Neoplasms, Uterine Cervical Neoplasms* / diagnosis, Colorectal Neoplasm, Early Detection of Cancer, Female, Humans, Mental Disorders, Prevalence, Quality of Life, Colorectal Neoplasms, Insurance, 03 medical and health sciences, 0302 clinical medicine, 2738 Psychiatry and Mental health, XXXXXX - Unknown, Health services and systems, Psychology, cancer, Women, Breast, Mortality, Public health, Uterine Cervical Neoplasms* / prevention & control, Individuals, Colorectal Neoplasms* / prevention & control, Cervical-Cancer, Breast Neoplasms* / diagnosis, mental illness, systematic reviews (medical research), 3. Good health, Early Detection of Cancer / statistics & numerical data, Mental Disorders / diagnosis, Breast Neoplasms* / prevention & control, Schizophrenia, Mental Disorder, Physical Health-Care, Colorectal Neoplasms* / diagnosis, Mental Disorders / physiopathology, 2803 Biological Psychiatry, Breast Neoplasm, Human
Beschreibung: Since people with mental illness are more likely to die from cancer, we assessed whether people with mental illness undergo less cancer screening compared with the general population.In this systematic review and meta-analysis, we searched PubMed and PsycINFO, without a language restriction, and hand-searched the reference lists of included studies and previous reviews for observational studies from database inception until May 5, 2019. We included all published studies focusing on any type of cancer screening in patients with mental illness; and studies that reported prevalence of cancer screening in patients, or comparative measures between patients and the general population. The primary outcome was odds ratio (OR) of cancer screening in people with mental illness versus the general population. The Newcastle-Ottawa Scale was used to assess study quality and I2 to assess study heterogeneity. This study is registered with PROSPERO, CRD42018114781.47 publications provided data from 46 samples including 4 717 839 individuals (501 559 patients with mental illness, and 4 216 280 controls), of whom 69·85% were women, for screening for breast cancer (k=35; 296 699 individuals with mental illness, 1 023 288 in the general population), cervical cancer (k=29; 295 688 with mental illness, 3 540 408 in general population), colorectal cancer (k=12; 153 283 with mental illness, 2 228 966 in general population), lung and gastric cancer (both k=1; 420 with mental illness, none in general population), ovarian cancer (k=1; 37 with mental illness, none in general population), and prostate cancer (k=6; 52 803 with mental illness, 2 038 916 in general population). Median quality of the included studies was high at 7 (IQR 6-8). Screening was significantly less frequent in people with any mental disease compared with the general population for any cancer (k=37; OR 0·76 [95% CI 0·72-0·79]; I2=98·53% with publication bias of Egger's p value=0·025), breast cancer (k=27; 0·65 [0·60-0·71]; I2=97·58% and no publication bias), cervical cancer (k=23; 0·89 [0·84-0·95]; I2=98·47% and no publication bias), and prostate cancer (k=4; 0·78 [0·70-0·86]; I2=79·68% and no publication bias), but not for colorectal cancer (k=8; 1·02 [0·90-1·15]; I2=97·84% and no publication bias).Despite the increased mortality from cancer in people with mental illness, this population receives less cancer screening compared with that of the general population. Specific approaches should be developed to assist people with mental illness to undergo appropriate cancer screening, especially women with schizophrenia.None.
Publikationsart: Article
Dateibeschreibung: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document; print
Sprache: English
ISSN: 2215-0366
DOI: 10.1016/s2215-0366(19)30414-6
Zugangs-URL: https://kclpure.kcl.ac.uk/portal/files/122133313/Disparities_in_cancer_screening_SOLMI_Acc7Oct2019Epub29Nov2019_GREEN_AAM.pdf
https://pubmed.ncbi.nlm.nih.gov/31787585
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=16904
https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=16904
http://hdl.handle.net/11588/801410
https://research-repository.griffith.edu.au/handle/10072/390133
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30414-6/fulltext
https://www.sciencedirect.com/science/article/pii/S2215036619304146
https://ir.ymlib.yonsei.ac.kr/handle/22282913/178983
https://espace.library.uq.edu.au/view/UQ:a52c465
https://yonsei.pure.elsevier.com/en/publications/disparities-in-cancer-screening-in-people-with-mental-illness-acr
https://kclpure.kcl.ac.uk/ws/files/122133313/Disparities_in_cancer_screening_SOLMI_Acc7Oct2019Epub29Nov2019_GREEN_AAM.pdf
https://kclpure.kcl.ac.uk/en/publications/320aacc4-3ffa-434b-a114-de060c42f5fd
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076532756&doi=10.1016/S2215-0366(19)30414-6&partnerID=40&md5=c6b0a0630997c43ef58789cfa7e87768
https://hdl.handle.net/11577/3383784
https://doi.org/10.1016/S2215-0366(19)30414-6
https://pure.manchester.ac.uk/ws/files/158250602/Cancer_Screening_manuscript_june28_CC_1_.docx
https://doi.org/10.1016/S2215-0366(19)30414-6
https://research.manchester.ac.uk/en/publications/b65cd1fb-33f6-467a-96dd-3d1a6e7ca34a
Rights: Elsevier TDM
CC BY NC ND
Dokumentencode: edsair.doi.dedup.....6e0724aa893ae7f6658516c4f5722a26
Datenbank: OpenAIRE
Beschreibung
Abstract:Since people with mental illness are more likely to die from cancer, we assessed whether people with mental illness undergo less cancer screening compared with the general population.In this systematic review and meta-analysis, we searched PubMed and PsycINFO, without a language restriction, and hand-searched the reference lists of included studies and previous reviews for observational studies from database inception until May 5, 2019. We included all published studies focusing on any type of cancer screening in patients with mental illness; and studies that reported prevalence of cancer screening in patients, or comparative measures between patients and the general population. The primary outcome was odds ratio (OR) of cancer screening in people with mental illness versus the general population. The Newcastle-Ottawa Scale was used to assess study quality and I2 to assess study heterogeneity. This study is registered with PROSPERO, CRD42018114781.47 publications provided data from 46 samples including 4 717 839 individuals (501 559 patients with mental illness, and 4 216 280 controls), of whom 69·85% were women, for screening for breast cancer (k=35; 296 699 individuals with mental illness, 1 023 288 in the general population), cervical cancer (k=29; 295 688 with mental illness, 3 540 408 in general population), colorectal cancer (k=12; 153 283 with mental illness, 2 228 966 in general population), lung and gastric cancer (both k=1; 420 with mental illness, none in general population), ovarian cancer (k=1; 37 with mental illness, none in general population), and prostate cancer (k=6; 52 803 with mental illness, 2 038 916 in general population). Median quality of the included studies was high at 7 (IQR 6-8). Screening was significantly less frequent in people with any mental disease compared with the general population for any cancer (k=37; OR 0·76 [95% CI 0·72-0·79]; I2=98·53% with publication bias of Egger's p value=0·025), breast cancer (k=27; 0·65 [0·60-0·71]; I2=97·58% and no publication bias), cervical cancer (k=23; 0·89 [0·84-0·95]; I2=98·47% and no publication bias), and prostate cancer (k=4; 0·78 [0·70-0·86]; I2=79·68% and no publication bias), but not for colorectal cancer (k=8; 1·02 [0·90-1·15]; I2=97·84% and no publication bias).Despite the increased mortality from cancer in people with mental illness, this population receives less cancer screening compared with that of the general population. Specific approaches should be developed to assist people with mental illness to undergo appropriate cancer screening, especially women with schizophrenia.None.
ISSN:22150366
DOI:10.1016/s2215-0366(19)30414-6